Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of $571.18 billion as of April 26, 2024. Its market cap has increased by 51.80% in one year.

Market Cap

571.18B

Enterprise Value

567.33B

1-Year Change

51.80%

Ranking

#13

Market Cap Chart

Since November 21, 2000, Novo Nordisk's market cap has increased from $3.99B to $571.18B, an increase of 14,205.49%. That is a compound annual growth rate of 23.58%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	567.31B	-0.29%
Apr 24, 2024	568.98B	-1.93%
Apr 23, 2024	580.17B	2.70%
Apr 22, 2024	564.92B	2.08%
Apr 19, 2024	553.42B	-0.03%
Apr 18, 2024	553.60B	-1.43%
Apr 17, 2024	561.63B	0.87%
Apr 16, 2024	556.76B	-0.36%
Apr 15, 2024	558.79B	-0.49%
Apr 12, 2024	561.54B	-0.71%
Apr 11, 2024	565.55B	0.38%
Apr 10, 2024	563.43B	0.06%
Apr 9, 2024	563.12B	-2.04%
Apr 8, 2024	574.84B	1.27%
Apr 5, 2024	567.63B	1.53%
Apr 4, 2024	559.06B	-2.39%
Apr 3, 2024	572.72B	0.42%
Apr 2, 2024	570.33B	-0.85%
Apr 1, 2024	575.25B	-0.66%
Mar 28, 2024	579.08B	0.27%
Mar 27, 2024	577.51B	-1.05%
Mar 26, 2024	583.64B	0.28%
Mar 25, 2024	582.02B	0.23%
Mar 22, 2024	580.71B	-0.82%
Mar 21, 2024	585.53B	-0.41%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	708.98B
UnitedHealth Group	448.23B
Johnson & Johnson	360.41B
Merck & Co.	321.34B
AbbVie	300.20B
AstraZeneca	219.62B
Thermo Fisher	219.33B
Novartis AG	190.33B

Market Cap Rankings